From: Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
Characteristics | Number of patients (percent) |
---|---|
Median age | 60 years (44–82) |
Sex | |
Male | 25 (38%) |
Female | 41 (62%) |
HIV status | |
Positive | 1 (2%) |
Negative | 65 (99%) |
Smoking status | |
Smoker (have ever) | 17 (26%) |
Non-smoker | 49 (74%) |
Alcohol consumption | |
Drinker | 17 (26%) |
Non-drinker | 49 (74%) |
ECOG status | |
0 | 42 (64%) |
1 | 19 (29%) |
2 | 3 (5%) |
3 | 2 (3%) |
4 | 0 (0%) |
Stage of tumor | |
I | 26 (39%) |
II | 15 (23%) |
III | 25 (38%) |
IV | 0(0%) |
Histology | |
Squamous cell carcinoma | 49 (74%) |
Squamous carcinoma (keratinizing) | 8 (12%) |
Squamous cell carcinoma (basaloid) | 5 (8%) |
Tubulovillous adenoma | 2 (3%) |
Adenocarcinoma | 2 (3%) |